Nurx, a San Francisco, CA-based digital practice for women’s health, raised an additional $22.5m in Series C funding round.
New investors Trustbridge, Comcast Ventures, and Wittington Ventures participated in the round along with existing investors Union Square Ventures and Kleiner Perkins Digital Growth Fund.
The company, which has raised $113m to date, will use the capital for patient growth, introduction of new sensitive health services, including treatment for headaches and migraines this month and expansion of its clinical, operations, and engineering teams in the near future.
Led by CEO Varsha Rao, Nurx is a health tech company providing personalized care for sensitive health needs, such as contraception, HIV prevention with PrEP, STI testing and treatment, and herpes treatment, which can be difficult to access and often carry shame and stigma. Today Nurx is available to 90 percent of the U.S. population.
Today Nurx provides care to more than 300,000 patients on a monthly basis, offering an “all in one” service by connecting patients, medical providers, and pharmacies in a single platform.
FinSMEs
11/08/2020